The study included 25 physicians and 4,163 patients. It was published in April issue of Gastroenterology.
Here are three findings:
1. Adenoma detection rate with traditional colonoscopes was 23.5 percent, while with the Fuse colonoscope the ADR rate was 28.9 percent ADR.
2. Additionally, the Fuse system identified more polyps per colon as compared to the traditional system.
3. EndoChoice, founded in 2008, serves more than 2,500 customers in the United States and works with distribution partners in 30 countries.
More articles on GI/endoscopy:
Texas Medical Association names Dr. Carlos Cardenas president-elect: 3 points
Mederi Therapeutics launches 3rd generation of Stretta technology: 5 things to know
Boston Scientific’s net sales of $1.96B in Q1 2016: 7 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.